Sign in

Trial site

Institut fuer Klinische Krebsforschung IKF GmbH

Frankfurt Am Main, 60488, GermanyNot linked to an institution yet
  • 1running trial
  • 2closed trials

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 1/21 trial
  • Phase 21 trial
  • Phase 31 trial
Status
  • Completed2 trials
  • Active, not recruiting1 trial
Lead sponsor
  • Glaxosmithkline Research & Development Limited1 trial
  • K-Group Beta Inc.1 trial
  • Mirati Therapeutics Inc.1 trial

Running trials

Closed trials

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026